Contributory role of endothelium and voltage-gated potassium channels in apocynin-induced vasorelaxations

Journal of Hypertension

Volumn 28, Issue 10, 2010, Pages 2102-2110

  Han, Wei Qing ^a,b,c   Wong, Wing Tak ^d   Tian, Xiao Yu ^d   Huang, Yu ^d   Wu, Ling Yun ^a,c   Zhu, Ding Liang ^a,b,c   Gao, Ping Jin ^a,b,c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c Shanghai Institute of Hypertension   (China)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

apocynin; endothelium; nitric oxide; potassium channel

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 4 AMINOPYRIDINE; APOCYNIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLIBENCLAMIDE; GUANYLATE CYCLASE INHIBITOR; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) TRANSHYDROGENASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; POTASSIUM CHANNEL; SERINE; VASCULAR CELL ADHESION MOLECULE 1; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; EXTRACELLULAR CALCIUM; FLUORESCENCE IMAGING; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION; WESTERN BLOTTING;

EID: 77957272376     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32833d0197     Document Type: Article

References (31)

1. Kitiyakara C, Chabrashvili T, Chen Y, Blau J, Karber A, Aslam S, et al. Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase. J Am Soc Nephrol 2003; 14:2775-2782.
2. Lee MY, Griendling KK. Redox signaling, vascular function, and hypertension. Antioxid Redox Signal 2008; 10:1045-1059.
3. Schuijt MP, Tom B, de Vries R, Saxena PR, Sluiter W, van Kats JP, et al. Superoxide does not mediate the acute vasoconstrictor effects of angiotensin II: a study in human and porcine arteries. J Hypertens 2003; 21:2335-2344.
4. Shastri S, Gopalakrishnan V, Poduri R, Di Wang H. Tempol selectively attenuates angiotensin II evoked vasoconstrictor responses in spontaneously hypertensive rats. J Hypertens 2002; 20:1381-1391.
5. Touyz RM. Activated oxygen metabolites: do they really play a role in angiotensin Il-regulated vascular tone? J Hypertens 2003; 21:22352238.
6. Williams HC, Griendling KK. NADPH oxidase inhibitors: new antihypertensive agents? J Cardiovasc Pharmacol 2007; 50:9-16.
7. Heumuller S, Wind S, Barbosa-Sicard E, Schmidt HH, Busse R, Schroder K, et al. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 2008; 51:211-217.
8. Baumer AT, Kruger CA, Falkenberg J, Freyhaus HT, Rosen R, Fink K, et al. The NAD(P)H oxidase inhibitor apocynin improves endothelial NO/ superoxide balance and lowers effectively blood pressure in spontaneously hypertensive rats: comparison to calcium channel blockade. Clin Exp Hypertens 2007; 29:287-299.
9. Virdis A, Colucci R, Fornai M, Duranti E, Giannarelli C, Bernardini N, et al. Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice. Hypertension 2007; 49:679-686.
10. Hu L, Zhang Y, Lim PS, Miao Y,Tan C, McKenzie KU, et al. Apocynin but not L-arginine prevents and reverses dexamethasone-induced hypertension in the rat. Am J Hypertens 2006; 19:413-418.
11. Hamilton CA, Brosnan MJ, Al-Benna S, Berg G, Dominiczak AF. NAD(P)H oxidase inhibition improves endothelial function in rat and human blood vessels. Hypertension 2002; 40:755-762.
12. Schluter T, Steinbach AC, Steffen A, Rettig R, Grisk O. Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition. Cardiovasc Res 2008; 80:271-279.
13. Tian J, Wong WT, Tian XY, Zhang P, Huang Y, Wang N. Rosiglitazone attenuates endothelin-1-induced vasoconstriction by upregulating endothelial expression of endothelin B receptor. Hypertension 2010; 56:129-135.
14. Chan W, Yao X, Ko W, Huang Y. Nitric oxide mediated endothelium-dependent relaxation induced by glibenclamide in rat isolated aorta. Cardiovasc Res 2000; 46:180-187.
15. Hercule HC, Schunck WH, Gross V, Seringer J, Leung FP, Weldon SM, et al. Interaction between P450 eicosanoids and nitric oxide in the control of arterial tone in mice. Arterioscler Thromb Vasc Biol 2009; 29:54-60.
16. Gomez JP, Ghisdal P, Morel N. Changes of the potassium currents in rat aortic smooth muscle cells during postnatal development. Pflugers Arch 2000; 441:388-397.
17. Sarantopoulos C, McCallum JB, Kwok WM, Hogan Q. Beta-escin diminishes voltage-gated calcium current rundown in perforated patch-clamp recordings from rat primary afferent neurons. J Neurosci Methods 2004; 139:61-68.
18. Langton PD, Nelson MT, Huang Y, Standen NB. Block of calcium-activated potassium channels in mammalian arterial myocytes by tetraethylammonium ions. Am J Physiol 1991; 260:H927-934.
19. Remillard CV, Leblanc N. Mechanism of inhibition of delayed rectifier K+ current by 4-aminopyridine in rabbit coronary myocytes. J Physiol 1996; 491 (Pt 2):383-400.
20. Standen NB, Quayle JM, Davies NW, Brayden JE, Huang Y, Nelson MT. Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. Science 1989; 245:177-180.
21. Bradley KK, Jaggar JH, Bonev AD, HeppnerTJ, Flynn ER, Nelson MT, et al. Kir2.1 encodes the inward rectifier potassium channel in rat arterial smooth muscle cells. J Physiol 1999; 515 (Pt 3):639-651.
22. Sadanaga T, Ohya Y, Ohtsubo T, Goto K, Fujii K, Abe I. Decreased 4-aminopyridine sensitive K+ currents in endothelial cells from hypertensive rats. Hypertens Res 2002; 25:589-596.
23. Nilius B, Viana F, Droogmans G. Ion channels in vascular endothelium. Annu Rev Physiol 1997; 59:145-170.
24. Cox RH. Molecular determinants of voltage-gated potassium currents in vascular smooth muscle. Cell Biochem Biophys 2005; 42:167-195.
25. Tammaro P, Smith AL, Hutchings SR, Smirnov SV. Pharmacological evidence for a key role of voltage-gated K+ channels in the function of rat aortic smooth muscle cells. Br J Pharmacol 2004; 143:303317.
26. Tanaka Y, Koike K, Toro L. MaxiK channel roles in blood vessel relaxations induced by endothelium-derived relaxing factors and their molecular mechanisms. J Smooth Muscle Res 2004; 40:125-153.
27. Simons JM, Hart BA, Ip Vai Ching TR, Van Dijk H, Labadie RP. Metabolic activation of natural phenols into selective oxidative burst agonists by activated human neutrophils. Free Radic Biol Med 1990; 8:251-258.
28. Stolk J, Hiltermann TJ, Dijkman JH, Verhoeven AJ. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am J Respir Cell Mol Biol 1994; 11:95102.
29. Matthiesen S, Lindemann D, Warnken M, Juergens UR, Racke K. Inhibition of NADPH oxidase by apocynin inhibits lipopolysaccharide (LPS) induced up-regulation of arginase in rat alveolar macrophages. Eur J Pharmacol 2008; 579:403-410.
30. Chan EC, Datla SR, Dilley R, Hickey H, Drummond GR, Dusting GJ. Adventitial application of the NADPH oxidase inhibitor apocynin in vivo reduces neointima formation and endothelial dysfunction in rabbits. Cardiovasc Res 2007; 75:710-718.
31. Gjertsen FB, Solheim E, Scheline RR. Metabolism of aromatic plant ketones in rats: acetovanillone and paeonol. Xenobiotica 1988; 18:225234.